WeightLoss

In a move that caps a heated contest for promising obesity therapies, Pfizer announced on Monday that it will purchase the U.S. biotech firm Metsera for approximately $10 billion in cash. The agreement puts an end to the bidding war that had seen the Danish pharmaceutical giant Novo Nordisk, the maker of...